The controversy over levels of sex steroids in cases with Alzheimer's disease.
Hogervorst
E
E
Department of Pharmacology, OPTIMA, University of Oxford, UK. eva.hogervorst@pharm.ox.ac.uk
Bandelow
S
S
D000368:Aged; D000544:Alzheimer Disease / Q000097:blood / Q000453:epidemiology*; D015897:Comorbidity; D018849:Controlled Clinical Trials as Topic / Q000592:standards*; D003430:Cross-Sectional Studies; D004967:Estrogens / Q000097:blood; D005260:Female; D006801:Humans; D007006:Hypogonadism / Q000097:blood / Q000453:epidemiology*; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D012016:Reference Values; D015983:Selection Bias; D013739:Testosterone / Q000097:blood
D004967:Estrogens; D013739:Testosterone